Essay
GLP-1 Drugs and Migraine: Evidence Guide
What GLP-1 agonists might mean for migraine, headache biology, metabolic drugs, clinical evidence, and what remains speculative.
The Edge of Epidemiology
History-haunted epidemiology, live reporting, and interactive public-health exhibits in one place.
Topic hub
Neuroepidemiology essays on migraine, cognition, epilepsy, dementia, Parkinson's disease, multiple sclerosis, and brain-health evidence.
Essays
This hub groups related writing so readers can move from one argument to the surrounding disease history, ecology, and evidence.
Essay
What GLP-1 agonists might mean for migraine, headache biology, metabolic drugs, clinical evidence, and what remains speculative.
Essay
A guide to the evidence on lithium and Alzheimer’s risk, including observational data, mechanisms, trial limits, and causal uncertainty.
Essay
Migraine brain fog, cognition, medication trade-offs, attack phases, and how cognitive symptoms complicate the lived burden of migraine.
Essay
Migraine is disabling and unevenly treated. Here is what the data says about who gets it, who lacks help, and why uncertainty remains.
Essay
A short migraine research note from the American Headache Society meeting, focused on clinical questions, evidence gaps, and field direction.
Essay
What new stem cell trials mean for Parkinson’s disease, safety, endpoints, clinical promise, and why the field still has no cure.
Essay
Why the relationship between cannabis and psychosis is not straightforward, including causality, confounding, dose, and psychiatric risk.
Essay
A personal and global-health look at epilepsy, seizure stigma, treatment gaps, public misunderstanding, and the burden of neurological disease.
Essay
Examining why multiple sclerosis risk increases with distance from the equator, including latitude, vitamin D, genetics, and environment.
Essay
A migraine research overview connecting neuroepidemiology, neuroscience, burden, treatment gaps, and recent literature.
Essay
An introduction to neuroepidemiology, including neurological disease patterns, risk factors, populations, surveillance, and public-health methods.